I think—and I touched on it in the presentation—just by lengthening out the patent process for non-generic drugs it's going to potentially cost employers, workers, unions, and our provincial government between $29 million to $56 million a year starting in 2023. That's going to have a major negative impact on the ability of benefit plans and the ability of the provincial government to do other programs, if they're going to have to absorb those costs.
On November 26th, 2013. See this statement in context.